Ironwood Pharmaceuticals Inc expected to post earnings of 8 cents a share - Earnings Preview

Ironwood Pharmaceuticals

25/02/2025 14:21

Ironwood Pharmaceuticals Inc IRWD.OQ IRWD.O is expected to show a fall in quarterly revenue when it reports  results on February 27 for the period ending December 31 2024

The Boston Massachusetts-based  company is expected to report a 20.2% decrease in revenue to $93.821 million from $117.55 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Ironwood Pharmaceuticals Inc is for earnings of 8 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Ironwood Pharmaceuticals Inc is $7.50​, above​ its last closing price of $1.80. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
0.06
0.08
0.02
Missed
-75.2
Jun. 30 2024
0.13
0.15
0.00
Missed
-100
Mar. 31 2024
0.15
0.19
-0.02
Missed
-110.5​
Dec. 31 2023
0.21
0.21
-0.01
Missed
-104.9
​​Sep. 30 2023
0.17
0.16
0.09
Missed
-42.9
Jun. 30 2023
0.26
0.25
0.31
Beat
25.7​
Mar. 31 2023
0.23
0.24
0.25
Beat
3.1
Dec. 31 2022
0.26
0.27
0.27
Met
0

This summary was machine generated February 25 at 14:21 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)